Intuitive Surgical, Inc. $ISRG Shares Sold by Hager Investment Management Services LLC

Hager Investment Management Services LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 300 shares of the medical equipment provider’s stock after selling 75 shares during the quarter. Hager Investment Management Services LLC’s holdings in Intuitive Surgical were worth $163,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of ISRG. Nuveen LLC acquired a new stake in shares of Intuitive Surgical during the first quarter worth about $1,715,899,000. Goldman Sachs Group Inc. lifted its holdings in shares of Intuitive Surgical by 26.1% during the first quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after purchasing an additional 566,979 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 1.4% in the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock valued at $16,178,258,000 after acquiring an additional 453,335 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $448.09 on Thursday. The stock has a market capitalization of $160.63 billion, a PE ratio of 62.50, a price-to-earnings-growth ratio of 4.64 and a beta of 1.61. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The business has a 50 day simple moving average of $460.50 and a 200-day simple moving average of $499.05.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business’s revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director directly owned 739 shares in the company, valued at approximately $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on ISRG shares. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday. BTIG Research restated a “buy” rating and issued a $571.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 1st. Royal Bank Of Canada restated an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. UBS Group upped their price objective on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. Finally, Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.